Dr. Lamontagne holds a Master’s degree in pharmacology and another in health research methodology. He was recruited as a critical care specialist and clinician-scientist by the Université de Sherbrooke and the Centre de recherche du CHU de Sherbrooke in 2010. Dr. Lamontagne has received peer-reviewed funds from the Canadian Institutes of Health Research, the Fonds de Recherche du Québec – Santé, the National Institute for Health Research, and the Lotte & John Hecht Memorial Foundation. His research activities include clinical trials of resuscitation interventions (65 Trial – PMID 32049269, LOVIT Trial – PMID 31915072), and knowledge translation activities such as trustworthy guidelines. In 2020, he was appointed co-Scientific Director of the CIHR-funded Canadian Sepsis Network, and co-Director of the Réseau québécois COVID-19 et pandémies funded by the Fonds de recherche du Québec – Santé.